Premutation Allele Combined with Caregiver Distress Factor Increase the Risk of Depression in Fragile X Carriers: Indonesia Setting
DOI:
https://doi.org/10.6000/2292-2598.2019.07.04.1Keywords:
Anxiety, depression, fragile X-associated disorders, premutation carriers, caregiver burden.Abstract
This study was done to determine the risk of anxiety and depression symptoms among fragile X premutation carriers. Hamilton anxiety rating scale (HARS) and Hamilton depression rating scale (HDRS) was administered by trained physicians to measure the severity of anxiety and depression symptoms, respectively. Caregiver distress factors which directly contribute to caregiver burden in particular degree of relationship with the child, number of FXS child, child institutional/educational status, number of hours spent providing care per day, and the degree of illness severity were documented. Thirty-one fragile X carriers (27 females, 4 males), aged 32-77 years participated in this study. Only 3.2% had anxiety symptoms, while depression symptoms were identified in 35.5% carriers. Number of hours of providing care/day were significantly associated with depression symptoms (p<0.001). The prevalence ratio (PR) of depression among individuals who had a distress score above cut-off was 3.2 (95% CI= 1.2 to 8.5) compared to those who had a distress score below cut-off with p=0.02. Fragile X premutation carriers are at a greater risk to develop depression symptoms related to the hours spent in caring for children with fragile X syndrome (FXS).
References
Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 2001; 3(3): 200-205. https://doi.org/10.1097/00125817-200105000-00010 DOI: https://doi.org/10.1097/00125817-200105000-00010
Nolin SL, Brown WT, Glicksman A, Houck GE, Gargano AD, Sullivan A, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 2003; 72: 454-464. https://doi.org/10.1086/367713 DOI: https://doi.org/10.1086/367713
Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 2000; 9(6): 901-908. https://doi.org/10.1093/hmg/9.6.901 DOI: https://doi.org/10.1093/hmg/9.6.901
Song FJ, Barton P, Sleightholme V, Yao GL, Fry-Smith A. Screening for fragile X syndrome: a literature review and modelling study. Health Technol Assess 2003; 7(16): 1-106. https://doi.org/10.3310/hta7160 DOI: https://doi.org/10.3310/hta7160
Hunter JE, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, et al. Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet 2012; 159B(5): 549-559. https://doi.org/10.1002/ajmg.b.32061 DOI: https://doi.org/10.1002/ajmg.b.32061
Roberts JE, Bailey DB, Jr., Mankowski J, Ford A, Sideris J, Weisenfeld LA, et al. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet 2009; 150B(1): 130-139. https://doi.org/10.1002/ajmg.b.30786 DOI: https://doi.org/10.1002/ajmg.b.30786
Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. Fragile X-Associated Neuropsychiatric Disorders (FXAND). Front Psychiatry 2018; 9: 564. https://doi.org/10.3389/fpsyt.2018.00564 DOI: https://doi.org/10.3389/fpsyt.2018.00564
Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006; 129(Pt 1): 243-255. https://doi.org/10.1093/brain/awh683 DOI: https://doi.org/10.1093/brain/awh683
Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve. Obstet Gynecol Surv 2010; 65(8): 523-530. https://doi.org/10.1097/OGX.0b013e3181f8bdda DOI: https://doi.org/10.1097/OGX.0b013e3181f8bdda
Kraan CM, Hocking DR, Bradshaw JL, Fielding J, Cohen J, Georgiou-Karistianis N, et al. Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome. Neurosci Biobehav Rev 2013; 37(3): 522-547. https://doi.org/10.1016/j.neubiorev.2013.01.010 DOI: https://doi.org/10.1016/j.neubiorev.2013.01.010
Lachiewicz A, Dawson D, Spiridigliozzi G, Cuccaro M, Lachiewicz M, McConkie-Rosell A. Indicators of anxiety and depression in women with the fragile X premutation: assessment of a clinical sample. J Intellect Disabil Res 2010; 54(7): 597-610. https://doi.org/10.1111/j.1365-2788.2010.01290.x DOI: https://doi.org/10.1111/j.1365-2788.2010.01290.x
Kohrt BA, Worthman CM. Gender and Anxiety in Nepal: The Role of Social Support, Stressful Life Events, and Structural Violence. CNS Neuroscience & Therapeutics 2009; 15(3): 237-248. https://doi.org/10.1111/j.1755-5949.2009.00096.x DOI: https://doi.org/10.1111/j.1755-5949.2009.00096.x
Albert PR. Why is depression more prevalent in women? Journal of Psychiatry & Neuroscience : JPN 2015; 40(4): 219-221. https://doi.org/10.1503/jpn.150205 DOI: https://doi.org/10.1503/jpn.150205
Roberts JE, Tonnsen BL, McCary LM, Ford AL, Golden RN, Bailey DB, Jr. Trajectory and Predictors of Depression and Anxiety Disorders in Mothers With the FMR1 Premutation. Biol Psychiatry 2016; 79(10): 850-857. https://doi.org/10.1016/j.biopsych.2015.07.015 DOI: https://doi.org/10.1016/j.biopsych.2015.07.015
Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, et al. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet 2005; 139B(1): 115-121. https://doi.org/10.1002/ajmg.b.30241 DOI: https://doi.org/10.1002/ajmg.b.30241
Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, et al. Protein composition of the intranuclear inclusions of FXTAS. Brain 2006; 129(Pt 1): 256-271. https://doi.org/10.1093/brain/awh650 DOI: https://doi.org/10.1093/brain/awh650
Greco CM, Tassone F, Garcia-Arocena D, Tartaglia N, Coffey SM, Vartanian TK, et al. Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol 2008; 65(8): 1114-1116. https://doi.org/10.1001/archneur.65.8.1114 DOI: https://doi.org/10.1001/archneur.65.8.1114
Brouwer JR, Mientjes EJ, Bakker CE, Nieuwenhuizen IM, Severijnen LA, Van der Linde HC, et al. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res 2007; 313(2): 244-253. https://doi.org/10.1016/j.yexcr.2006.10.002 DOI: https://doi.org/10.1016/j.yexcr.2006.10.002
Nabeshima T, Kim HC. Involvement of genetic and environmental factors in the onset of depression. Exp Neurobiol 2013; 22(4): 235-243. https://doi.org/10.5607/en.2013.22.4.235 DOI: https://doi.org/10.5607/en.2013.22.4.235
Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65(2): 190-200. https://doi.org/10.1001/archgenpsychiatry.2007.26 DOI: https://doi.org/10.1001/archgenpsychiatry.2007.26
Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol 2009; 72(1): 67-73. https://doi.org/10.1016/j.ijpsycho.2008.03.014 DOI: https://doi.org/10.1016/j.ijpsycho.2008.03.014
Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. Psychoneuroendocrinology 2005; 30(10): 1010-1016. https://doi.org/10.1016/j.psyneuen.2005.04.006 DOI: https://doi.org/10.1016/j.psyneuen.2005.04.006
Adams PE, Adams JS, Nguyen DV, Hessl D, Brunberg JA, Tassone F, et al. Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet 2010; 153B(3): 775-785. DOI: https://doi.org/10.1002/ajmg.b.31046
Mundhofir FEP, Winarni TI, Nillesen W, van Bon BWM, Schepens M, Ruiterkamp-Versteeg M, et al. Prevalence of fragile X syndrome in males and females in Indonesia. World Journal of Medical Genetics 2012; 2(3): 15. https://doi.org/10.5496/wjmg.v2.i3.15 DOI: https://doi.org/10.5496/wjmg.v2.i3.15
WHO. A Glossary of Terms for Community Health Care and Services. In: Development CfH, editor. Geneva: WHO; 2005.
Hamilton M. The assesment of anxiety states by rating. J Med Psychol 1959; 32: 50-55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x DOI: https://doi.org/10.1111/j.2044-8341.1959.tb00467.x
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62. https://doi.org/10.1136/jnnp.23.1.56 DOI: https://doi.org/10.1136/jnnp.23.1.56
Guy W. Clinical Global Impression (CGI). In: Department of Health E, and Welfare, editor. United States1976.
Tape TG. Interpretation of Diagnostic Tests. Ann Intern Med 2001; 135(1). https://doi.org/10.7326/0003-4819-135-1-200107030-00043 DOI: https://doi.org/10.7326/0003-4819-135-1-200107030-00043
Reiss AL, Freund L, Abrams MT, Boehm C, Kazazian H. Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet 1993; 52(5): 884-894. https://doi.org/10.1097/00006254-199310000-00004 DOI: https://doi.org/10.1097/00006254-199310000-00004
Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, et al. A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry 2009; 70(6): 852-862. https://doi.org/10.4088/JCP.08r04476 DOI: https://doi.org/10.4088/JCP.08r04476
Seltzer MM, Barker ET, Greenberg JS, Hong J, Coe C, Almeida D. Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychol 2012; 31(5): 612-622. https://doi.org/10.1037/a0026528 DOI: https://doi.org/10.1037/a0026528
Pao M, Bosk A. Anxiety in medically ill children/adolescents. Depress Anxiety 2011; 28(1): 40-49. https://doi.org/10.1002/da.20727 DOI: https://doi.org/10.1002/da.20727
Stein DJ, Ruscio AM, Lee S, Petukhova M, Alonso J, Andrade LH, et al. Subtyping social anxiety disorder in developed and developing countries. Depress Anxiety 2010; 27(4): 390-403. https://doi.org/10.1002/da.20639 DOI: https://doi.org/10.1002/da.20639
Koenig HG. Research on religion, spirituality, and mental health: a review. Can J Psychiatry 2009; 54(5): 283-291. https://doi.org/10.1177/070674370905400502 DOI: https://doi.org/10.1177/070674370905400502
Lippman LH, Keith JD. The demographics of spirituality among youth: International perspectives. In: Roehlkepartain EC, King PE, Wagener L, Benson PL, editors. The Handbook of spiritual development in childhood and adolescence. Thousand Oaks, California: Sage Publication Inc.; 2006. DOI: https://doi.org/10.4135/9781412976657.n8
Weiss MJ. Hardiness and social support as predictors of stress in mothers of typical children, children with autism, and children with mental retardation. Autism 2002; 6(1): 115-130. https://doi.org/10.1177/1362361302006001009 DOI: https://doi.org/10.1177/1362361302006001009
Sahoo S, Khess CR. Prevalence of depression, anxiety, and stress among young male adults in India: a dimensional and categorical diagnoses-based study. J Nerv Ment Dis 2010; 198(12): 901-904. https://doi.org/10.1097/NMD.0b013e3181fe75dc DOI: https://doi.org/10.1097/NMD.0b013e3181fe75dc
Addis ME. Gender and depression in men. Clin Psychol Sci Prac 2008; 15: 153-168. https://doi.org/10.1111/j.1468-2850.2008.00125.x DOI: https://doi.org/10.1111/j.1468-2850.2008.00125.x
Chee KY, Tripathi A, Avasthi A, Chong MY, Xiang YT, Sim K, et al. Country variations in depressive symptoms profile in Asian countries: Findings of the Research on Asia Psychotropic Prescription (REAP) studies. Asia Pac Psychiatry 2015; 7(3): 276-285. https://doi.org/10.1111/appy.12170 DOI: https://doi.org/10.1111/appy.12170
Johnston C, Eliez S, Dyer-Friedman J, Hessl D, Glaser B, Blasey C, et al. Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet 2001; 103(4): 314-319. https://doi.org/10.1002/ajmg.1561 DOI: https://doi.org/10.1002/ajmg.1561.abs
Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, et al. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet 2008; 38(5): 493-502. https://doi.org/10.1007/s10519-008-9214-3 DOI: https://doi.org/10.1007/s10519-008-9214-3
Hessl D, Wang JM, Schneider A, Koldewyn K, Le L, Iwahashi C, et al. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biol Psychiatry 2011; 70(9): 859-865. https://doi.org/10.1016/j.biopsych.2011.05.033 DOI: https://doi.org/10.1016/j.biopsych.2011.05.033
Perlick DA, Berk L, Kaczynski R, Gonzalez J, Link B, Dixon L, et al. Caregiver burden as a predictor of depression among family and friends who provide care for persons with bipolar disorder. Bipolar Disorders 2016; 18(2): 183-191. https://doi.org/10.1111/bdi.12379 DOI: https://doi.org/10.1111/bdi.12379
Wheeler AC, Skinner DG, Bailey DB. Perceived quality of life in mothers of children with fragile X syndrome. American Journal of Mental Retardation 2008; 113(3): 159-177. https://doi.org/10.1352/0895-8017(2008)113[159:PQOLIM]2.0.CO;2 DOI: https://doi.org/10.1352/0895-8017(2008)113[159:PQOLIM]2.0.CO;2
Almeida DM, McGonagle K, King H. Assessing daily stress processes in social surveys by combining stressor exposure and salivary cortisol. Biodemography Soc Biol 2009; 55(2): 219-237. https://doi.org/10.1080/19485560903382338 DOI: https://doi.org/10.1080/19485560903382338
Downloads
Published
How to Cite
Issue
Section
